Eric Marandett and Irina Oberman Khagi on the Ariosa Decision

View "Ariosa V. Sequenom Signals Trouble Ahead For Life Sciences"

Eric Marandett and Irina Oberman Khagi wrote "Ariosa V. Sequenom Signals Trouble Ahead For Life Sciences," in Intellectual Property Law360 where they discuss the Federal Circuit's recent decision in the Ariosa case.  They explain that the decision can potentially place at risk patents directed to diagnostic methods, vaccine technology, gene therapy and personalized medicine techniques that have been the subject of significant research and development investment in recent years.  The article also appeared in Life Sciences Law360 and Appellate Law360.